. . .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . .family slam health trust after pensioner's 'undignified' death http://lm360.us/Ingenito-father-of-Foret-from-Volodarskiy?Baunefath=235 most read .